Coluracetam
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2008 (NCT00621270)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- ChondrocyteSupplementation
Chondrocyte supplementation
Chemistry & pharmacology
Loading structure…
SMILES
Cc1oc2nc3c(c(NC(=O)CN4CCCC4=O)c2c1C)CCCC3- Mol. weight
- 341.41 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL37935 ↗
Also known as
- bci-540
- bci-540
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00621270 | Phase 2 | Jan 1, 2008 | BrainCells Inc., University of British Columbia |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| BrainCells Inc. | For profit | 1 | 1 | 1 | 2008 |
| University of British Columbia | Academic/Hospital | 1 | 0 | 1 | 2008 |
2 organizations
Page 1 / 1